Tesaro's ovarian cancer drug Zejula added to Cancer Drugs Fund

1 June 2018 - Tesaro's ovarian cancer drug Zejula (niraparib), the first PARP inhibitor shown to be effective in patients ...

Read more →

Pfizer's Xalkori makes it onto Cancer Drugs Fund

31 May 2018 - NICE has published draft guidance recommending that Pfizer's Xalkori (crizotinib) to treat ROS1-positive advanced non-small-cell lung ...

Read more →

NICE says OK to Keytruda for bladder cancer via the Cancer Drugs Fund

16 March 2018 - Becomes the first immunotherapy recommended for urothelial cancer after chemotherapy. ...

Read more →

Once a day pill for ovarian cancer could be made available on the CDF

8 February 2018 - NICE has invited Tesaro to submit a proposal for including niraparib (Zejula) in the Cancer Drugs Fund ...

Read more →

Patients to benefit from myeloma treatment through CDF deal

7 February 2018 - Up to 1,600 patients with multiple myeloma could benefit from a new oral pill after NICE recommends ...

Read more →

CDF to save NHS £140m over five years

31 January 2018 - At least £140 million is expected to be released into the NHS over the next five ...

Read more →

Roche’s Tecentriq available via CDF

7 December 2017 - Roche’s Tecentriq will be available on the NHS in England via the Cancer Drugs Fund for ...

Read more →

Merck invited to submit a CDF proposal for Merkel cell cancer drug

27 November 2017 - NICE has asked Merck to submit a Cancer Drugs Fund proposal for an immunotherapy called avelumab. ...

Read more →

Roche’s skin cancer drug Erivedge pulled from CDF

13 October 2017 - Roche’s Erivedge could be removed from the Cancer Drugs Fund within months after the National Institute ...

Read more →

Patients getting faster access to cancer drugs as NICE approves three quarters of the Cancer Drugs Fund

10 August 2017 - Liver cancer drug, sorafenib has been approved for routine NHS use, marking three quarters of the way ...

Read more →

Merck’s Keytruda, Lilly’s Lartruvo available via CDF

5 July 2017 - Patients with certain forms of lung cancer or sarcoma have now gained access to two new ...

Read more →

Cancer Drugs Fund driving early access to promising new treatments

28 June 2017 - NHS patients in England are getting early access to new drugs for lung cancer and sarcoma, ...

Read more →

Cancer Drugs Fund of minimal benefit

6 June 2017 - A new study has concluded that the medicines available in the previous version of the NHS Cancer ...

Read more →

Britain backs first-line use of Merck's Keytruda under cancer fund

31 May 2017 - Britain's cost-effectiveness agency NICE has decided that Merck & Co's immunotherapy drug Keytruda can be used ...

Read more →

Conservatism and the cancer drugs fund

24 May 2017 - Are some patients—and some people— more deserving than others? ...

Read more →